DYLAN JOVINE #1 TAKEOVER TARGET FOR APRILOne small biotech Big Pharma is watching is our “#1 Takeover Target for April. Recently won an approval from FDA for a certain type of cancer.
that makes it the first targeted therapy for patients with a certain type of cancer. Appears it is a targeted therapy for Leukemia.
Is there any information on this stock.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
MEI Pharma (MEIP). It was not hard for me to figure out with the clues he gave, most notably, MEI received FDA fast track approval in early April for its lymphoma drug and recently received a $100M investment from a foreign pharma.